TRIVARX LTD — Director's Dealing 2025

Dec 18, 2025

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity TrivarX Limited ABN 58 008 130 336

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Christopher Ntoumenopoulos
Date of last notice	2 December 2025

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	1. Direct 2. Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	1. Christopher Ntoumenopoulos & Leo Ntoumenopoulos 2. Sobol Capital Pty Ltd (Relevant interest under section 608(3) of the Corporations Act)
Date of change	19 December 2025
No. of securities held prior to change	Sobol Capital Pty Ltd • 9,711,638 Ordinary fully paid shares • 2,362,500 Options expiring 13 October 2026 @ $0.06 • 3,000,000 Options expiring 9 July 2027 @ $0.06 • 3,000,000 Options expiring 9 July 2027 @ $0.08 • 4,000,000 Options expiring 4 December 2027 @ $0.045 • 7,000,000 Options expiring 2 December 2028 @ $0.025

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class	1. Ordinary fully paid shares 2. A) Ordinary fully paid shares B) Options expiring 19 December 2030 @ $0.015
Number acquired	1. 6,250,000 2. A) 5,000,000 B)75,000,000
Number disposed	-
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	1. $50,000 2. A) $40,000 B) Estimated $457,500
No. of securities held after change	Direct Christopher Ntoumenopoulos & Leo Ntoumenopoulos • 6,250,000 Ordinary fully paid shares Sobol Capital Pty Ltd • 14,711,638 Ordinary fully paid shares • 2,362,500 Options expiring 13 October 2026 @ $0.06 • 3,000,000 Options expiring 9 July 2027 @ $0.06 • 3,000,000 Options expiring 9 July 2027 @ $0.08 • 4,000,000 Options expiring 4 December 2027 @ $0.045 • 7,000,000 Options expiring 2 December 2028 @ $0.025 • 75,000,000 Options expiring 19 December 2030 @ $0.015
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back	1. Issued under Tranche 2 of the Placement and approved by shareholders at the general meeting held on 12 December 2025. 2. A) Issued under Tranche 2 of the Placement and approved by shareholders at the general meeting held on 12 December 2025. B) Facilitators options issued for services provided in introducing and facilitating the acquisition of Nucleics and approved by shareholders at the general meeting held on 12 December 2025.

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	N/A
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3